ESC Clinical Practice Guidelines on Cardio-Oncology:

signs of cardiotoxicity are found early to reduce the chances of them developing into serious complications. If you are at risk, a personal monitoring plan will be put together so any signs can be detected quickly. How can my doctor and I assess my risk of developing cardiotoxicity? The ESC Guidelines describe the factors that increase the risk of cardiotoxicity of cancer treatments. These include a personâ€™s age, whether they have had previous cancer therapies, their cardiovascular risk factors (such as blood pressure) and lifestyle (including diet and exercise). The ESC Guidelines contain risk assessment tools, which will help your oncologist or haematologist determine your risk level. By asking you certain questions about your medical history and carrying out baseline tests, your medical team can determine your risk profile and develop a treatment plan specifically for you. Common examples of cardiotoxicity risk factors Age, sex, genetics Previous Cardiovascular cardiovascular risk factors disease Cardiotoxicity Previous Lifestyle risk cardiotoxic cancer factors therapies Abnormalities in electrocardiograms, echocardiograms and blood tests What can I do to stay healthy and well? A healthy lifestyle can reduce your risk of developing a heart or circulation problem when you start taking your cancer therapy and improve your
